Peptide InjectionsAI
High evidence

Liraglutide

Peptide therapy: benefits, side effects, cost and protocols

C172H265N43O51

3,751 g/mol / CID 16134956 / Acylated GLP-1 analog
C172H265N43O51

Liraglutide, sold under the brand names Victoza and Saxenda, is a GLP-1 receptor agonist used to treat type 2 diabetes and chronic obesity. It is given by subcutaneous injection and was one of the first GLP-1 agonists approved for weight management.

ByChris Riley(CFA)|Updated

Sources: FDA / PubMed / ClinicalTrials.gov View

Lowest listed
$179/mo
FDA status
FDA-approved drug
Evidence
Strong Evidence

Liraglutide prices, lowest first

2 listings, $179 to $299 per month.

We may earn a commission at no extra cost to you. Disclosure

Liraglutide listed prices by provider
ProviderPer monthLink
Henry Meds
Generic Liraglutide / daily injection
ClinicalRx
$179LowestVisit
HimsOut of stock
Generic Liraglutide / [unverifiable on public site Jul 2026]
503A CompoundedClinical
$299Visit

Prices shown are estimates based on publicly available data and may not reflect current pricing. Actual costs may vary by location, insurance, dosage, and formulation. Always verify directly with the provider.

Who Liraglutide is usually considered for

  • Weight management
  • Blood sugar regulation
  • Cardiovascular risk reduction
  • Appetite suppression
  • Phase 4

How Liraglutide works

GLP-1 receptor agonist that mimics incretin hormones to regulate appetite, slow gastric emptying, and improve blood sugar control.

Key studies

6,055 papers on PubMed

  1. 01

    Liraglutide and Renal Outcomes in Type 2 Diabetes

  2. 02

    Mann JFE, Ørsted DD, Brown-Frandsen K et al

    N Engl J Med / RCT

  3. 03

    Liraglutide reduced risk of diabetic kidney disease progression and macroalbuminuria development

  4. 04

    Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

  5. 05

    Marso SP, Daniels GH, Brown-Frandsen K et al

    N Engl J Med / RCT

  6. 06

    Liraglutide reduced cardiovascular death, MI, or stroke by 13% in type 2 diabetes

  7. 07

    Glycemia Reduction in Type 2 Diabetes - Glycemic Outcomes

  8. 08

    GRADE Study Research Group, Nathan DM, Lachin JM et al

    N Engl J Med / RCT

    Liraglutide and glargine were more effective than glimepiride and sitagliptin at maintaining target hemoglobin A1c.

  9. 09

    Liraglutide and glargine were more effective than glimepiride and sitagliptin at maintaining target hemoglobin A1c

  10. 10

    A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

Liraglutide compound data

C172H265N43O51
3751 g/mol
16134956 ↗
(2S)-5-[[(5S)-5-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-4-carboxy-butanoyl]amino]acetyl]amino]-3-hydroxy-butanoyl]amino]-3-phenyl-propanoyl]amino]-3-hydroxy-butanoyl]amino]-3-hydroxy-propanoyl]amino]-3-carboxy-propanoyl]amino]-3-methyl-butanoyl]amino]-3-hydroxy-propanoyl]amino]-3-hydroxy-propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methyl-pentanoyl]amino]-4-carboxy-butanoyl]amino]acetyl]amino]-5-oxo-pentanoyl]amino]propanoyl]amino]propanoyl]amino]-6-[[(1S)-1-[[(1S)-1-benzyl-2-[[(1S,2S)-1-[[(1S)-2-[[(1S)-2-[[(1S)-1-[[(1S)-1-[[(1S)-1-[[2-[[(1S)-1-(carboxymethylcarbamoyl)-4-guanidino-butyl]amino]-2-oxo-ethyl]carbamoyl]-4-guanidino-butyl]carbamoyl]-2-methyl-propyl]carbamoyl]-3-methyl-butyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-methyl-2-oxo-ethyl]carbamoyl]-2-methyl-butyl]amino]-2-oxo-ethyl]carbamoyl]-3-carboxy-propyl]amino]-6-oxo-hexyl]amino]-2-(hexadecanoylamino)-5-oxo-pentanoic acid

Liraglutide questions

What is LIRAGLUTIDE?

Liraglutide is a first-generation GLP-1 receptor agonist used for weight management (Saxenda) and type 2 diabetes (Victoza). Developed by Novo Nordisk, it requires daily injection and has shown cardiovascular risk reduction benefits.

How does LIRAGLUTIDE work?

GLP-1 receptor agonist that mimics incretin hormones to regulate appetite, slow gastric emptying, and improve blood sugar control.

Is LIRAGLUTIDE legal to buy?

LIRAGLUTIDE requires a prescription from a licensed healthcare provider. It is legal to purchase with a valid prescription from authorized pharmacies.

Where can I buy LIRAGLUTIDE?

LIRAGLUTIDE is available by prescription through compounding pharmacies and telehealth providers. Browse our verified provider directory to find trusted sources.

What category does LIRAGLUTIDE belong to?

LIRAGLUTIDE is primarily classified as a weight loss & metabolic peptide. Peptides researched for their effects on weight management, fat metabolism, appetite regulation, and metabolic enhancement. This category includes GLP-1 agonists, dual/triple agonists, and other metabolic peptides.

What are the research benefits of LIRAGLUTIDE?

LIRAGLUTIDE has been studied for: Weight management, Blood sugar regulation, Cardiovascular risk reduction, Appetite suppression. First-generation daily GLP-1 agonist. Marketed as Saxenda (weight loss) and Victoza (diabetes).

Liraglutide in the news

News aggregated via Google News. Inclusion does not imply endorsement.

Considering Liraglutide?

The 2-minute quiz matches you with licensed providers who offer it. A clinician decides if it fits.

Take the quiz